Senior Director, Medical Writing
Location: Remote, US
About GondolaBio
GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors. GondolaBio aims to leverage cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases.
Who You Are
You are a seasoned regulatory medical writing leader who takes clinical and regulatory documents from first draft to final, submission-ready version. You have authored and led the preparation of key documents that move programs forward — protocols, investigator brochures, clinical study reports, IND applications, briefing documents, and submission modules — and you know health authority guidance and public disclosure requirements well enough to apply them with judgment, not just by checklist. You work well with study teams, keep reviews moving, resolve conflicting comments, and make sure every message in a document is supported by the data. You are comfortable owning your documents end to end in a small, fast-moving company, and you are ready to take on more as our programs grow. You influence without authority, bring clarity to complex data, and see process improvement and vendor management as core parts of the job.
The ideal candidate has:
Key Responsibilities
Clinical Documents
Regulatory Submissions
Quality & Process
Review Management & Collaboration
Job details are sourced from the employer's original posting.
Open job postingAbout the company
This company is involved in clinical pharmacology and early clinical development, focusing on early clinical sciences and development strategy from first-in-human through Phase 2. They also lead quantitative sciences including data analytics, pharmacometrics, biostatistics, and data management to inform dose selection and program development.